Skip to Main Content

Author Details

Yvonne A Evrard
Frederick National Laboratory for Cancer Research, Inc.
1998
29
19
PMIDPaper TitleJournal TitlePublished Year
36960342Data augmentation and multimodal learning for predicting drug response in patient-derived xenografts from gene expressions and histology images.Front Med (Lausanne)2023
34524425A cross-study analysis of drug response prediction in cancer cell lines.Brief Bioinform2022
34996889Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment.Nat Commun2022
34001007Learning curves for drug response prediction in cancer cell lines.BMC Bioinformatics2021
34429404Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment.Nat Commun2021
34158060TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository.J Transl Med2021
34211076Publisher Correction: Converting tabular data into images for deep learning with convolutional neural networks.Sci Rep2021
34059739Converting tabular data into images for deep learning with convolutional neural networks.Sci Rep2021
32152150Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis.Cancer Res2020
33093487Ensemble transfer learning for the prediction of anti-cancer drug response.Sci Rep2020
32933072Enhanced Co-Expression Extrapolation (COXEN) Gene Selection Method for Building Anti-Cancer Drug Response Prediction Models.Genes (Basel)2020
31632915AI Meets Exascale Computing: Advancing Cancer Research With Large-Scale High Performance Computing.Front Oncol2019
30577754Predicting tumor cell line response to drug pairs with deep learning.BMC Bioinformatics2018
29092942PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models.Cancer Res2017
27001313Pharmacodynamic Response of the MET/HGF Receptor to Small-Molecule Tyrosine Kinase Inhibitors Examined with Validated, Fit-for-Clinic Immunoassays.Clin Cancer Res2016
27663481Pharmacodynamic analyses in a multi-laboratory network: lessons from the poly(ADP-ribose) assay.Semin Oncol2016
27663478Promise and limits of the CellSearch platform for evaluating pharmacodynamics in circulating tumor cells.Semin Oncol2016
23284638Development and validation of an immunoassay for quantification of topoisomerase I in solid tumor tissues.PLoS One2012
20103672Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cells.Clin Cancer Res2010
20924131Development of a validated immunofluorescence assay for γH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity.Clin Cancer Res2010
20966046Mediation of CTCF transcriptional insulation by DEAD-box RNA-binding protein p68 and steroid receptor RNA activator SRA.Genes Dev2010
19683498Gcn5 and SAGA regulate shelterin protein turnover and telomere maintenance.Mol Cell2009
17440986Developmental potential of Gcn5(-/-) embryonic stem cells in vivo and in vitro.Dev Dyn2007
17325035Loss of Gcn5 acetyltransferase activity leads to neural tube closure defects and exencephaly in mouse embryos.Mol Cell Biol2007
15937931GCN5 and p300 share essential functions during early embryogenesis.Dev Dyn2005
14991404Alterations in Ca2+-dependent and cAMP-dependent signaling pathways affect neurogenesis and melanogenesis of quail neural crest cells in vitro.Dev Genes Evol2004
12660246c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation.J Biol Chem2003
11017084Loss of Gcn5l2 leads to increased apoptosis and mesodermal defects during mouse development.Nat Genet2000
9690473lunatic fringe is an essential mediator of somite segmentation and patterning.Nature1998
  • 1 - 29 of 29

Recommended Authors

Komal S Rathi
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2014
Number of shared co-authors 3
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 0
Tuo Zhang
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
Myung Chang Lee
Stanford University
Career Start Year 2012
Number of shared co-authors 0
Rahul K Kollipara
McDermott Center for Human Growth and Development.
Career Start Year 2010
Number of shared co-authors 2
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 1
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Career Start Year 2008
Number of shared co-authors 2
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 6
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 1
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 6
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 1
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 7
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 2
Mariano J Alvarez
Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center
Career Start Year 2000
Number of shared co-authors 3
Wenyan Zhong
Oncology R&D
Career Start Year 2000
Number of shared co-authors 1
Jan Koster
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 6
Yan Liu
Chengdu Medical College
Career Start Year 1999
Number of shared co-authors 1
Marc Vooijs
Maastricht University Medical Centre+
Career Start Year 1997
Number of shared co-authors 1
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 4
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Samuel Aparicio
University of British Columbia
Career Start Year 1993
Number of shared co-authors 9
David E Root
Broad Institute of Harvard and MIT
Career Start Year 1993
Number of shared co-authors 7
Glenn S Cowley
Broad Institute of Harvard and MIT
Career Start Year 1990
Number of shared co-authors 2
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 6
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 5
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 5
Dirk Geerts
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 1
David J Adams
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 13
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 7

Collaborators

James H Doroshow
National Cancer Institute, National Institutes of Health
Co-authored papers 18
Thomas Brettin
University of Chicago
Co-authored papers 9
Fangfang Xia
University of Chicago
Co-authored papers 8
Maulik Shukla
University of Chicago
Co-authored papers 8
Rick Stevens
Argonne National Laboratory
Co-authored papers 8
Hyunseung Yoo
Translational Research Center, Inha University Hospital
Co-authored papers 6
Michael T Lewis
Baylor College of Medicine
Co-authored papers 3
Alana L Welm
Huntsman Cancer Institute, University of Utah
Co-authored papers 3
Matthew H Bailey
Department of Biology at Brigham Young University
Co-authored papers 2
Matthew A Wyczalkowski
Washington University in St Louis
Co-authored papers 2
Reyka G Jayasinghe
Washington University in St Louis
Co-authored papers 2
Ramaswamy Govindan
Siteman Cancer Center, Washington University School of Medicine
Co-authored papers 2
Cynthia X Ma
Co-authored papers 2
Robert J Mashl
Washington University in St. Louis
Co-authored papers 2
Jeremy Hoog
Co-authored papers 2
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Co-authored papers 2
Chia-Kuei Mo
Co-authored papers 2
Sergei Maslov
University of Illinois Urbana-Champaign
Co-authored papers 2
Yves Pommier
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Michael C Wendl
Washington University in St Louis
Co-authored papers 2
Meenhard Herlyn
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Co-authored papers 2
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 2
Sherri R Davies
Co-authored papers 2
Tina Primeau
Co-authored papers 2
John F DiPersio
Washington University School of Medicine
Co-authored papers 2
Nadezhda V Terekhanova
Co-authored papers 2
Feng Chen
Washington University in St Louis
Co-authored papers 2
Matthew J Ellis
Co-authored papers 2
Shunqiang Li
Co-authored papers 2
Yize Li
Co-authored papers 2
Release 1.2